incretin and glp-1 Incretin-based therapy of metabolic disease Incretins role in metabolic homeostasis

The most efficient way to produce ATP is by breaking down glucose, a simple sugar derived from the carbohydrates we consume

MACE was significantly lower for patients taking a GLP-1 RA (14.9 versus 18.5), with a hazard ratio of 1.25 for those not on a GLP-1 RA

Both are acceptable

18, 2025 /PRNewswire/ -- Neurogan Health , a brand known for clean, science-driven innovation, today has introduced AHK-CU + GHK-CU Hair Serum Pro , the first serum spray to combine 2,400mg of GHK-Cu and 2,400mg of AHK-Cu in a precise 1:1 ratio

#Pharma #Biotech #ObesityTreatment #ClinicalTrials To view or add a comment, sign in Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1 Less than two weeks after Pfizer struck a deal with Sciwind Biosciences to gain commercial rights to a GLP-1 drug, Chinas National Medical Products Administration (NMPA) has approved the treatment for patients with obesity